Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

Journal of Clinical Microbiology

Volumn 46, Issue 3, 2008, Pages 887-891

  Garrido, Carolina ^a   Roulet, Vanessa ^b,c   Chueca, Natalia ^d   Poveda, Eva ^a   Aguilera, Antonio ^e   Skrabal, Katharina ^b,c   Zahonero, Natalia ^a   Carlos, Silvia ^d   García, Federico ^d   Faudon, Jean Louis ^b   Soriano, Vincent ^a   De Mendoza, Carmen ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Eurofins Medinet Inc   (Germany)

^c BioAlliance Pharma   (France)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^e HOSPITAL DE CONXO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; VIROGENESIS; VIRUS DETECTION;

ADULT; ANTIGENS, CD4; COMPUTATIONAL BIOLOGY; FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHENOTYPE; REAGENT KITS, DIAGNOSTIC; RECEPTORS, CCR5; RECEPTORS, CXCR4; SENSITIVITY AND SPECIFICITY;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 40749106626     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01611-07     Document Type: Article

References (36)

1. Andreoletti, L., K. Skrabal, V. Perrin, N. Chomont, S. Saragosti, G. Gresenguet, H. Moret, J. Jacques, J. D. D. Longo, M. Matta, F. Mammano, and L. Belec. 2007. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naïve clade A human immunodeficiency virus type 1-infected women. J. Clin. Microbiol. 45:1838-1842.
2. Berger, E., R. Doms, E. Fenyo, B. Korber, D. Littman, J. Moore, Q. Satten tau, H. Schuitemaker, J. Sodroski, and R. Weiss. 1998. A new classification for HIV-1. Nature 391:240.
3. Brumme, Z., J. Goodrich, H. Mayer, C. Brumme, B. Henrick, B. Wynhoven, J. Asselin, P. Cheung, R. Hogg, J. Montaner, and P. Harrigan. 2005. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. J. Infect. Dis. 192:466-474.
4. Chueca, N., M. Alvarez, M. Casañas, E. Poveda, C. Garrido, V. Guillot, N. Zahonero, V. Soriano, C. de Mendoza, and F. García. 2007. A comparison of 7 different tools available to predict coreceptor usage based on V3 genetic sequences, abstr. 53. Abstr. 5th Eur. HIV Drug Resist. Wkshp., Cascais, Portugal.
5. Cormier, E., and T. Dragic. 2002. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76:8953-8957.
6. Delobel, P., M. T. Nugeyre, M. Cazabat, C. Pasquier, B. Marchou, P. Massip, F. Barre-Sinoussi, N. Israel, and J. Izopet. 2007. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J. Clin. Microbiol. 45: 1572-1580.
7. de Mendoza, C., C. Rodriguez, F. Garcia, J. M. Eiros, L. Ruiz, E. Caballero, A. Aguilera, P. Leiva, J. Colomina, F. Gutierrez, J. del Romero, J. Aguero, V. Soriano, and the Spanish HIV Seroconverter Study Group. 2007. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J. Antimicrob. Chemother. 59:698-704.
8. Holm-Hansen, C., E. Baan, B. Asjo, F. Pascu, J. Goudsmit, and J. De Jong. 2000. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. AIDS Res. Hum. Retrovir. 16:867-870.
9. Holm-Hansen, C., D. Grothues, S. Rustad, B. Rosok, F. Pascu, and B. Asjo. 1995. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res. Hum. Retrovir. 11:597-603.
10. Huang, W., S. Eshleman, J. Toma, S. Fransen, E. Stawiski, E. Paxinos, J. Whitcomb, A. Young, D. Donnell, F. Mmiro, P. Musoke, L. Guay, J. Jackson, N. Parkin, and C. Petropoulos. 2007. Co-receptor tropism in subtype D HIV-1: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J. Virol. 81:7885-7893.
11. Hunt, P., P. Harrigan, W. Huang, M. Bates, D. Williamson, J. McCune, R. Price, S. Spudich, H. Lampiris, R. Hoh, T. Leigler, J. Martin, and S. Deeks. 2006. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J. Infect. Dis. 194:926-930.
12. Jensen, M., F. Li, A. van't Wout, D. Nickle, D. Shriner, H. He, and S. McLaughlin. 2003. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77:13376-13388.
13. Jensen, M., M. Coetzer, A. van't Wout, L. Morris, and J. Mullins. 2006. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J. Virol. 80:4698-4704.
14. Kaleebu, P., I. Nankya, D. Yirrell, L. Shafer, J. Kyosiimire-Lugemwa, D. Lule, D. Morgan, S. Beddows, J. Weber, and J. Whitworth. 2007. Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J. Acquir. Immune Defic. Syndr. 45:28-33.
15. Koot, M., I. Keet, A. Vos, R. de Goede, M. Roos, R. Coutinho, F. Miedema, P. Schellekens, and M. Tersmette. 1993. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118:681-688.
16. Kuiken, C., J. de Jong, E. Baan, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:4622-4627.
17. Laeyendecker, O., X. Li, M. Arroyo, F. McCutchan, R. Gray, M. Wawer, D. Serwadda, F. Nalugoda, G. Kigozi, T. Quinn, and the Rakai Health Science Program. 2006. The effect of HIV subtype on rapid progression in Rakai, Uganda, abstr. 44LB. Abstr. 13th Conf. Retrovir. Opportun. Infect., Denver, CO.
18. Low, A., D. Chan, W. Dong, T. Sing, R. Swanstrom, M. Jensen, S. Pillai, B. Good, V. Dias Lima, and P. Harrigan. 2007. Current implementations of HIV genotyping algorithms are inadequate for the prediction of X4 coreceptor usage in clinical isolates from population-based V3 sequences: approaches to improvement. Antivir. Ther. 12:S164.
19. Moyle, G., A. Wildfire, S. Mandalia, H. Mayer, J. Goodrich, J. Whitcomb, and B. Gazzard. 2005. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. J. Infect. Dis. 191:866-872.
20. Ndung'u, T., E. Sepako, M. McLane, F. Chand, K. Bedi, S. Gaseitsiwe, F. Doualla-Bell, T. Peter, I. Thior, S. Moyo, P. Gilbert, V. Novitsky, and M. Essex. 2006. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 347:247-260.
21. Pastore, C., R. Nedellec, A. Ramos, S. Pontow, L. Ratner, and D. Mosier. 2006. HIV type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J. Virol. 80:750-758.
22. Pérez-Alvarez, L., M. Muñoz, E. Delgado, C. Miralles, A. Ocampo, V. Garcia, M. Thomson, G. Contreras, R. Nájera, and the Spanish group for Antiretroviral Resistance Studies in Galicia. 2006. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia Spain. J. Med. Virol. 78:1520-1528.
23. Pillai, S., B. Good, D. Richman, and J. Corbeil. 2003. A new perspective on V3 phenotype prediction. AIDS Res. Hum. Retrovir. 19:145-149.
24. Ping, L., J. Nelson, I. Hoffman, J. Schock, S. Lamers, M. Goodman, P. Vernazza, P. Kazembe, M. Maida, D. Zimba, M. Goodenow, J. Eron, S. Fiscus, M. Cohen, and R. Swanstrom. 1999. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underepresentation of X4 variants. J. Virol. 73:6271-6281.
25. Poveda, E., V. Briz, M. Quiñones-Mateu, and V. Soriano. 2006. HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20:1359-1367.
26. Poveda, E., V. Briz, V. Roulet, M. González, J. L. Faudon, K. Skrabal, M. González, and V. Soriano. 2007. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use. AIDS 21: 1487-1490.
27. Resch, W., N. Hoffman, and R. Swanstrom. 2001. Improved success of phenotype prediction of the HIV type 1 from envelope variable loop 3 sequence using neural networks. Virology 288:51-62.
28. Richman, D., and S. Bozzette. 1994. The impact of the syncytium-inducing phenotype of HIV on disease progression. J. Infect. Dis. 169:968-974.
29. Roulet, V., S. Rochas, J. L. Labernardiere, F. Mammano, J. L. Faudon, N. Raja, S. Lebel-Binay, and K. Skabal. 2007. HIV PHENOSCRIPT ENV: a sensitive assay for the detection of HIV X4 minority species and determination of non-B subtype viral tropism, abstr. 617. Abstr. 14th Conf. Retrovir. Opportun. Infect., Los Angeles, CA.
30. Sander, O., T. Sing, I. Sommer, A. Low, P. Cheung, P. Harrigan, T. Lengauer, and F. Domingues. 2007. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput. Biol. 3:e58.
31. Schuitemaker, H., M. Koot, N. Kootstra, M. Dercksen, R. de Goede, R. van Steenwijk, J. Lange, J. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-1360.
32. Sing, T., N. Beerenwinkel, and T. Lengauer. 2004. Learning mixtures of localized rules by maximizing the area under the ROC curve, p. 89-96. In J. Hernández-Orallo, N. Lachiche, and P. Flach (ed.), The ROCAI-2004 International Workshop on ROC Analysis in Artificial Intelligence, Valencia, Spain.
33. Skrabal, K., A. Low, W. Dong, T. Sing, P. Cheung, F. Mammano, and P. Harrigan. 2007. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model. J. Clin. Microbiol. 45:279-284.
34. Tscherning, C., A. Alaeus, R. Fredriksson, A. Bjorndal, H. Deng, D. Littman, E. Fenyo, and J. Albert. 1998. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241:181-188.
35. Tscherning-Casper, C., D. Vödrös, E. Menu, K. Aperia, R. Fredriksson, G. Dolcini, G. Chaouat, F. Barré-Sinoussi, J. Albert, E. Fenyö, et al. 2000. Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. J. Acquir. Immune Defic. Syndr. 24:1-9.
36. Weber, J., H. Piontkivska, and M. Quinones-Mateu. 2006. HIV type 1 tropism and inhibitors of viral entry: clinical implications. AIDS Rev. 8:60-77.